Report of the 4th joint meeting of the WHO Global Advisory Committee on Vaccine Safety and the Advisory Committee on Safety of Medicinal Products, 12–14 November 2024

Overview

The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999, and the Advisory Committee on Safety of Medicinal Products (ACSoMP) was established in 2003, to provide independent, authoritative scientific advice to WHO on issues of vaccine and medicine safety of global or regional concern. The 3-day hybrid meeting of ACSoMP and GACVS, held on 12–14 November 2024, included topics specific to vaccine safety, pharmacovigilance issues common to both vaccines and medicines and topics specific to medicines safety.